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Mastitis in prepartum dairy heifers has been recognized as a significant economic 
problem for the dairy industry.  Intramammary infusion of cephapirin sodium was completed in 
20 treatment animals and the results were compared to 25 non-treated control animals.  
Bacteriological data from the quarter milk samples were used to determine and compare initial 
infection rates and cure rates following calving between treatment and control groups.  
Comparisons were also made between groups for differences in reproductive performance, milk 
yield, somatic cell count and milk ketone concentration.   
Milk yield did not differ between groups for either DHIA monthly average kg/day, 305 
day actual milk yield or 305 day mature equivalent yield (305ME).  The average weekly milk 
weights (kg/d) between groups were different (P<.05). Reproductive performance between 
groups was not significantly different.  Milk ketone concentration did not differ at weeks 1 or 2.  
Somatic cell count score (SCS) at 200 days in milk were not different between groups, but the 
treatment group exhibited a trend towards lower cell counts (P<.15).  SCS in the treatment group 
tended to be lower (P<.15) during the average of the first 3 DHIA test periods.  Prepartum 
treatment of dairy heifers significantly improved cure rates in the treatment group (P<.05), 
moderately reduced SCC throughout lactation, and did not affect milk yield.  While there were 
no significant differences between treatment groups in milk ketone concentrations, evidence 
suggests that infections caused by major mastitis pathogens may increase metabolic stress on 
primiparous heifers.  Further research in the use of prepartum lactating cow antibiotics in heifers 
is needed.   
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 CHAPTER 1. INTRODUCTION 
Mastitis continues to be a major problem in the dairy industry resulting in lost income, shortened 
productive life, decreased animal quality of life, and decreased milk quality.  Estimated financial losses for 
the industry approach $2 billion annually.  Annual losses in states such as New York and Louisiana have 
been estimated at $150 million and $15 million, respectively (39, 47).  Recent loss estimates total $184.40 
per cow/year total (4).  Reduced production accounts for more than half of the lost income, while discarded 
milk, animal replacement costs, extra labor, medication, and veterinary services are further contributors.  
Proven control measures based on scientific research have decreased the prevalence of mastitis in most 
herds.  Only in the past 20 years has heifer mastitis been identified as a major cause of lost income and 
decreased animal performance.  There are several reasons why heifer intramammary infections (IMI) 
should be of concern to the dairy industry: 1.) IMI in heifers adversely affects proper growth and 
proliferation of mammary secretory cells, affecting future production (81).  2.) Heifers may serve as new 
vectors of contagious mastitis pathogens in herds that otherwise practice good mastitis management (69).  
3.) Heifers infected at the onset of lactation may be at higher risk for problems related to sub-clinical and 
clinical mastitis.  These problems include decreased reproductive performance (2, 24, 72), increased 
likelihood of elevated somatic cell count (46), and increased risk of premature culling.  As a result, the 
animal’s genetic potential for milk production may never be reached.  Research to date indicates that 
antibiotics may be a feasible way to control new IMI in heifers when prevention has failed.  Mastitis in 
prepartum, primigravid heifers may be more likely cured or prevented, in comparison to mastitis in 
lactating cows (42, 52, 53).  As dairy herds increase in size and pressure increases to reduce the national 
somatic cell count standard, mastitis control and prevention will become more important, especially that 
related to spread of contagious infections such as those caused by Staphylococcus aureus. 
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CHAPTER 2. LITERATURE REVIEW 
2.1 Prevalence and Economics 
Intramammary infection rates in heifers can be as high as 97% (46).  Staphylococcus 
aureus is perhaps the best example of a mastitis pathogen present in heifers that continues to 
cause significant financial losses despite increased knowledge in the fields of dairy management, 
microbiology, pharmacology, and biotechnology.  Staphylococcus aureus is considered a major 
contagious mastitis pathogen.  It has been isolated from nulliparous, primigravid, primiparous, 
and multiparous animals.  Prevalence of S. aureus in prepartum and primigravid heifers ranges 
from 2.6 to 37.1%, (15, 38, 65, 82, 83), with percentage of infected quarters ranging from 0.7 to 
15.4% (50, 52, 56, 65, 73, 82).  Staphylococcus aureus has also been found to account for 2.4 to 
46.2% of all intramammary infections (IMI) in primiparous animals near parturition (38, 44, 46, 
48, 82, 83).  Prevalence of S. aureus in postpartum, primiparous heifers ranges from 2.8 to 
20.4% (15, 38, 68), with the percentage of infected quarters ranging from 0.4 to 3.4 (34, 38, 49).  
Wilson et al., (90) and Fox et al. (12) found S. aureus prevalence in mixed parity animals to 
range from 9.1 to 33.7%.  Using data from multiparous cows, Mathews et al. (34) found that 
2.3% of all quarters were infected before calving and that 0.6% of quarters were infected with S. 
aureus postcalving.  It is understandable that the percentage of S. aureus-infected animals and 
quarters varies, as S. aureus IMI have proven difficult to consistently culture and isolate.  
Estimates indicate that 75 to 91% of S. aureus IMI are found in the first attempt to culture, with 
98% confirmed with three attempts (75, 76).   
Staphylococcus aureus infections in breeding age heifers may occur as early as 9 months of 
age and persist for periods of 1 year or more, even into the first lactation.  The consequences of 
S. aureus IMI are clear.  These early infections may damage mammary development and impair 
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milk production for the animals’ productive life (46, 81).  Natzke et al. (39) found that 305-day 
milk yield decreased by 773 kg when one quarter was infected with S. aureus.  Wilson et al. (91) 
estimated financial losses of $185.51 per case of S. aureus based on 305-day mature equivalent 
milk yield compared with uninfected herdmates.  Jaenicke et al. (26) found that when heifers 
were infused with dry cow antibiotics prepartum, net revenue increased $174.92 due to increased 
milk production.  Decreased reproductive performance (2, 72) may occur due to S. aureus IMI.  
Additionally, premature culling may be necessary to control S. aureus.  
2.2 Modes of Transmission 
Various mechanisms of transmission have been identified, including flies (21, 58) and 
fomites found in the milking parlor, such as milking equipment, milkers’ hands, common udder 
cloths, and strip cups (11).  Boddie et al. (3) found IMI prevalence of 5.2% in herds that 
practiced fly control vs. 55.2% in herds that did not.  Milk droplet impacts on teat ends due to 
malfunctioning milking equipment may also induce new S. aureus IMI (4).  Literature indicates 
that S. aureus can be isolated from the environment, mammary secretions, streak canals, and/or 
body sites of most dairy animals (33, 69, 70).  Researchers have concluded that reservoirs for 
infection are most likely udders of infected heifers and cows (69).  Staphylococcus aureus 
isolated and “fingerprinted” as those bacteria responsible for IMI were found to most likely 
originate from S. aureus-infected milk or body sites and could be transmitted from animal to 
animal by flies (21, 69).  Additional means of transmission include calves suckling other calves, 
especially those fed waste or mastitic milk (41, 66).  It is possible that all mechanisms of spread 
of S. aureus IMI are not yet known. 
2.3 Pathology and Virulence Factors 
In addition to being commonly isolated from dairy animals, S. aureus is highly pathogenic 
 4
and persistent in the mammary gland.  Virulence factors possessed by S. aureus are partially 
responsible for the subclinical, chronic type of mastitis that causes damage to secretory cells of 
the mammary gland (17, 35, 80).  Staphylococcus aureus IMI cannot be solely characterized as 
subclinical and chronic. In rare cases, S. aureus mastitis can be peracute, gangrenous, and fatal 
(77).  Literature indicates that not all virulence factors relevant to S. aureus IMI have been 
discovered (78).  Known virulence factors help S. aureus to evade the host’s immune defense 
and resist infused or parenteral antibiotics.  Hyaluronidase is an enzyme possessed by S. aureus 
that enables it to penetrate mammary tissue to which it has adhered.  Microabcesses form and 
eventually develop scar tissue which is impermeable to antibiotics.  Staphylococcus aureus can 
be released if the microabcesses or scar tissue breaks down.  This contributes to chronicity, 
clinical flare-ups, and the ability of the infection to spread further within the gland.  
Staphylococcus aureus also possesses another enzyme, coagulase, which is used to differentiate 
S. aureus from other Staphylococcus species.  Coagulase reacts with inflammation products, 
yielding fibrin-like clots.  These clots inhibit leukocyte mobility and hinder the action of the 
host’s immune system phagocytes.  These clots may also prevent drainage of milk from ducts of 
the gland and lead to stasis or destruction of secretory cells (4).   
Staphylococcus aureus also releases toxins, including alpha, beta, gamma, and delta toxins.  
Of these, alpha toxin appears to be the most toxic.  It is particularly harmful to mammary tissues 
causing vasoconstriction, which leads to localized ischemia and cell necrosis (22).  In times of 
rapid S. aureus growth, the effects of alpha toxin may lead to gangrenous mastitis (4).  
Additionally, Foster et al. (10) noticed a lack of macrophages and neutrophils in areas where 
alpha toxin-producing S. aureus were growing in in vitro mouse mastitis models.  The authors 
theorized that this was due to decreased chemotaxis of macrophages and neutrophils into regions 
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where alpha toxin-positive bacteria were growing.  Early research found that beta and gamma 
toxins were mostly tissue irritants, with beta toxin being the most predominant toxin of S. aureus 
isolated from animals (22).  However, beta toxin has been found to increase bacterial growth in 
in vitro mouse mastitis experiments (10).   
Capuco et al. (5) found that alpha and beta toxins and leukocidin caused cell damage and 
decreased secretory activity in mammary explants.  More recent research indicates that alpha and 
beta toxins may play a significant role in S. aureus adherence to mammary epithelial cells.  Some 
research has contradicted the idea that adherence is necessary for establishment of S. aureus IMI 
(1).  Cifrian et al. (6) evaluated factors affecting S. aureus adherence to cultured mammary 
epithelial cells.  Their data suggested that cellular damage by alpha toxin is a necessary step for 
S. aureus adherence in the mammary gland.  However, the authors were unsure whether S. 
aureus adhered to cells damaged solely by the alpha toxin or to cells with exposed basement 
membrane and cellular matrix.  Cifrian and Guidry (7) later found that S. aureus adherence to 
cultured mammary epithelial cell monolayers was reduced when both alpha and beta toxins were 
neutralized by antibodies to alpha and beta toxins.  They felt that this information indicated that 
alpha and beta toxins could influence S. aureus virulence by increasing the ability of S. aureus to 
adhere to mammary tissue.  This study (7) agrees with earlier results (6), in that damage caused 
by alpha and/or beta toxins is at least partially responsible for S. aureus adherence to mammary 
epithelial cells.  In addition, the later data (7) suggested that the bacterial cell wall and not the 
capsule contained the adherence factors.  Frost et al., (18) and Wanasinghe (86) studied the 
ability of S. aureus to adhere to epithelial cells and found that adherence to mammary epithelial 
cells improved S. aureus pathogenicity.  Adherence is made possible by bacterial surface 
fibronectin binding protein which binds to fibronectin present on the surface of mammary 
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epithelial cells (43, 84).  This binding is dependent on the number of binding sites (83).  Froman 
et al. (17) and Wadstrom et al. (85) indicated that epithelial damage is required for S. aureus to 
adhere to and colonize tissue.  In fact, when a vaccine against these fibronectin-binding proteins 
was used in lactating Jersey cattle, new IMI decreased by 35.8% (43).  Leukocidin is another 
virulence factor that interferes with the mammary cell’s immune system.  Leukocidin interferes 
with phagocytosis by causing cytolysis of both polymorphonuclear leukocytes (PMN) and 
macrophages (14, 22).  
Components of the cell wall of S. aureus can also contribute to virulence.  The chief 
component, peptidoglycan, causes delayed hypersensitivity which can lead to flare-ups in 
chronic cases of subclinical S. aureus in which additional tissue damage results (22).  A second 
component, teichoic acid, can be converted to teichuronic acid in vivo.  The cell-mediated 
immune system (CMI) and humoral immune system may not recognize teichuronic acid after the 
conversion (22).  Indeed, Sutra et al.(80) found that masking of teichoic acid was favored when 
S. aureus was grown on SA 110 agar or milk agar.  They hypothesized that this may lead to 
increased resistance to phagocytosis by polymorphonuclear leukocytes (PMNs).  Protein A is the 
third cell wall component that may contribute to S. aureus virulence by binding to the Fc portion 
of IgG.  By doing this, Protein A prevents opsonization of S. aureus by IgG (14, 22).  However, 
there are two subtypes of IgG, IgG1 and IgG2.  Protein A binds strongly to IgG2, but only weakly 
binds to IgG1 (79). Ruminant neutrophils have Fc receptors for IgG2 only (87), and IgG2 
concentration increases during clinical mastitis (63).  Given the high specificity of Protein A for 
IgG2, and the relatively low milk concentration of IgG2, this may indicate a lesser role of Protein 
A in S. aureus virulence (22).  However, Pankey et al. (64) found that a Protein A vaccine 
increased spontaneous cure rate and decreased somatic cell counts in cows indicating a 
 7
significant role of Protein A in S. aureus virulence.  Some strains of S. aureus may also form 
capsules or pseudocapsules (slime layer) (79).  These may cover cell wall antigens and inhibit 
opsonization by complement and antibodies to cell wall components (79, 89).  In concurrence, 
Nickerson (43) indicated that the S. aureus pseudocapsule/slime layer was sufficient to impede 
antibody and complement attachment, which would block phagocytosis.  In fact, when cows 
were immunized with a vaccine designed to promote opsonization of the S. aureus capsule, 
phagocytic activity improved (23).  Last of the virulence factors are “superantigens”, which are 
controversial in their existence in S. aureus IMI.  It has been hypothesized that the alpha, beta, 
gamma, delta toxins and leukocidin may be superantigens.  Production of superantigens may 
lead to symptoms of shock immunosuppression in the host (32).  Superantigens strongly 
stimulate all T-cell subtypes in an assortment of species.  Literature indicates that superantigens 
can have detrimental effects on the function of CMI, actually diluting the cell populations 
necessary for specific immunity (32).  The best known example of a superantigen is the 
staphylococcal enterotoxin B (32).  Additional research needs to be done to fully understand and 
isolate possible superantigens possessed by S. aureus that cause bovine IMI (14). 
 Staphylococcus aureus can continue to resist the effects of antibiotics and/or the immune 
system if the microabcesses and scar tissue present from an established infection are bypassed.  
Literature indicates that the presence of milk in the gland can lower the efficacy of infused 
antibiotics (55, 59) and the effectiveness of the host intramammary immune phagocytes (62, 80).  
Presence of β-lactamase enzyme and conversion to L-forms are two additional ways S. aureus 
can avoid lysis in the mammary environment.  β-lactamase (penicillinase) is an enzyme found in 
some strains of S. aureus that causes hydrolysis of the β-lactam ring.  The β-lactamase enzyme 
of S. aureus has shown variability from herd to herd.  This may be due to cow individuality and 
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antibiotic treatment habits.  In one study, resistance to penicillin by S. aureus ranged from 0 to 
60% between herds, with an overall average of 7% resistance (60).  Additionally, S. aureus can 
be induced to L-forms.  It is thought that L-forms of S. aureus act as a transition stage to survive 
conditions such as disruption of bacterial cell wall synthesis by antibiotics that are deleterious to 
cellular integrity.  Cell survival is possible due to lack of an organized cell wall in these S. 
aureus L-forms.  L-forms provide S. aureus with benefits that include the ability to withstand 
antibiotic therapy, persist in the mammary gland, and re-emerge (flare-up) when conditions 
improve (54).  Owens (54) noted that cows experimentally infected with 106 cfu vs. 103 cfu S. 
aureus had higher incidence of L-form S. aureus in mammary secretions.  The author felt that the 
increased inflammation and subsequent increase in pH, electrolytes, and serum proteins present 
in the mammary secretions of cows infused with the higher concentration of S. aureus may have 
played an influential role in increasing in vivo L-form induction.  This agrees with the work of 
Young and Dahlquist (92) who found that a high osmolality (5%) was optimal for induction, 
growth, and maintenance of L-forms of S. aureus in rabbits.  It may be possible that an influx of 
proteins and ions, especially sodium and chloride, into the mammary gland during inflammation 
may provide conditions for L-form induction.  Lastly, it appears that S. aureus can use 
phagocytes to protect itself from antibiotics.  Staphylococcus aureus can be engulfed and 
withstand the lytic effects of PMNs (8,9).  Furthurmore, Craven and Anderson (9) reasoned that 
antibiotics did not eradicate phagocytized intracellular S. aureus due to reduced bacterial growth 
rate within phagocytes, despite data showing that leukocyte permeability to some antibiotics may 
increase when S. aureus is engulfed by leukocytes.  If the organisms are in a metabolically 
inactive or inert state, then antibiotics will have little or no effect on decreasing microbial cell 
wall integrity.    
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2.4 Control and Prevention 
While S. aureus IMI may be difficult to eradicate, literature indicates it can be controlled.  
Proper milking procedure and hygiene may be the easiest and most economical way to control S. 
aureus IMI (25).  Data indicates that teat and udder skin should be healthy before milking and 
free of sores, wounds, or chapping where S. aureus could colonize the teat end and surrounding 
skin (13).  Cleanliness at milking time is also important.  Minimal use of water and premilking 
teat antisepsis may reduce new S. aureus IMI (42).  Additionally, the advent of postmilking teat 
antisepsis has been important in contributing to decreasing contagious IMI such as S. aureus.  
Natzke, et al (39) and Oliver and Mitchell (50) found that when teats were dipped after milking 
and cows were treated with penicillin-dihydrostreptomycin at dry-off, IMI caused by major 
mastitis pathogens decreased by 75% and 45%, respectively.  Postdipping alone has been 
estimated to decrease the rate of new IMI by 50% (45).  In another effort to decrease new S. 
aureus IMI, the effect of segregating S. aureus-infected animals and noninfected animals was 
tested (12, 91).  Fox and Hancock (12) found no significant differences among herds that 
segregated S. aureus-infected cows and those that did not.  Conversely, Wilson et al. (91) found 
that S. aureus prevalence decreased from 29.5 to 16.3%, while somatic cell count decreased from 
600,000 cell/ml to 345,000 cells/ml in herds where S. aureus cows were segregated.  Since S. 
aureus is a contagious mastitis pathogen that can be spread at milking, it appears that segregation 
is an acceptable form of control in herds where it is feasible and beneficial when other steps are 
taken simultaneously to control S. aureus.  Additional ways to control and prevent S. aureus 
include the use of lactating and dry cow antibiotics in pregnant heifers and dry cows.  Lactating 
cow therapy may be used to control S. aureus IMI.  Lactating cow therapy alone may cure 30.4% 
of animals and 25% of quarters (41).  Lactating cow therapy in conjunction with a S. aureus 
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bacterin was shown to decrease somatic cell count from 492,000 cells/ml to 84,000 cells/ml (74).  
Lactation cow therapy in conjunction with parenteral antibiotic treatment was found to cure 48% 
of animals and 51.4% of quarters (61).  Dry cow therapy in adult cattle can be expected to 
prevent between 50 and 80% of new S. aureus IMI during the dry period (41).  Literature 
indicates that dry cow treatment in primigravid heifers may reduce new S. aureus IMI by more 
than 90% (52, 56, 57, 83).  Fortunately, heifer mastitis, when compared to lactating cow mastitis, 
may be more easily cured and/or prevented through the use of management practices, vaccines, 
and antibiotics.  
Additionally, the advent of biotechnology may introduce new methods of controlling S. 
aureus IMI. (51). Perhaps the best current example is the work done by Kerr et al. (28) on the 
expression of the lysostaphin gene in mice.  Lysostaphin has the ability to lyse the 
Staphylococcus spp. cell wall.  In laboratory experiments, mice with the transgenic gene were 
experimentally infected with S. aureus.  Mice with the gene were able to lactate, reproduce, and 
function normally, but more importantly, mice with high levels of expressed lysostaphin 
remained uninfected after 104 cfu/50 µl/gland S. aureus was inoculated via intramammary 
infusion.  Similar studies have not been reported in the bovine.  Biotechnology may be helpful in 
the control and prevention of S. aureus IMI, in addition to management practices, vaccines, and 
antibiotics. 
2.5 Effect on Reproduction and Metabolic State 
Heifer mastitis may have negative effects on metabolic state and reproductive performance 
of animals in early lactation (31).  Research regarding the relation between ketone bodies and the 
immune system has been conflicting (16, 29).  Research dealing with mastitis and ketone bodies 
has focused on coliform types of mastitis. Little work has been done on mastitis caused by gram- 
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positive pathogens (30, 31).  From the limited research available, it appears that cows and heifers 
in negative energy balance are at increased risk for intramammary infection.  Whether major or 
minor pathogens have a metabolic effect on heifers or cows in early lactation remains a largely 
untested hypothesis.   
Reproductive performance in animals with clinical or sub-clinical mastitis is likely to be 
impaired (2, 24, 72).  Little, if any, research exists on this topic with regards to primiparous 
heifers.  It can be extrapolated from research examining reproduction in lactating animals that 
infections acquired by primiparous heifers in the prepartum period can have an effect on the 
subsequent lactation.  
In conclusion, current knowledge implicates S. aureus as a major mastitis pathogen in 
heifers and lactating dairy animals.  Staphylococcus aureus and Staphylococcus spp. compose a 
large portion of infections found in unbred and primigravid heifers.  However, it appears that 
Staphylococcus spp. IMI have a significant percentage of spontaneous elimination in the 
mammary gland, when compared to S. aureus.  Considering the information presented in this 
review, efforts focusing on preventing or treating IMI caused by S. aureus may be beneficial.  
For these reasons, we sought to evaluate the efficacy of administration of lactating cow 
antibiotics in heifers two weeks pre-partum.  This project is being completed as part of the NE-
1009 regional mastitis research mission.  Universities across North America will be completing 
the project, using the same protocol, and the data will be pooled and presented as a group paper, 





CHAPTER 3.  MATERIALS AND METHODS 
3.1 Animal Assignment and General Management 
Forty six primigravid Jersey heifers from the Hill Farm Research Station dairy herd were 
randomly assigned to treatment or control groups.  Eartags were assigned consecutively to 
heifers at birth.  Animals with even numbered ear tags (n=21) were assigned to the treatment 
group while animals with odd numbered ear tags were assigned to the control group (n=25).  
Assignment based on eartag number was standard procedure in the NE-1009 multistate protocol 
that this trial was part of.  There was no bias applied to the numbering of heifers related to milk 
production.  Additionally, statistical analysis was performed and there were no differences in age 
of enrollment in the study between experimental groups (P=.90).  Treatment heifers averaged 
25.2 months of age with a range of 19-33 months, while control heifers averaged 25.3 months of 
age with a range of 21-32 months at calving.  Overall, heifer numbers favored the odd numbered 
heifers (control).  This was due to greater death losses and culling within heifers with even 
numbered ear tags prior to beginning this study.  In addition, one even numbered heifer was 
dropped from the study due to the extremely long period of time (55 days) between first 
sampling and calving.  This heifer was bred by natural service and no breeding date was 
available.  Average time from antibiotic infusion to parturition was 16 days.  Control animals 
received no infusion.  The study was initiated in January 2002 and completed in April 2003.  
Heifers were housed on Bermuda grass pastures during the spring, summer and fall months, and 
had access to rye grass pastures during the winter months.  All heifers received 2 kg of a 
commercial 16% crude protein dairy pellet daily.  Heifers were bred by either artificial 
insemination (n=31) or natural service to an Angus bull (n=14).  Approximately 14 days prior to 
calving, heifers were moved into the close up dry cow area.  The dry cow area consisted of a 6 
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acre pasture containing 2 sheds bedded with sand.  Shade was provided by trees.  After moving 
to the dry cow area, heifers received 1 kg of a 16% dairy pellet and 1 kg of a 50% anionic salt/ 
50% grist type grain mix, in addition to ad libitum bermuda grass hay. After parturition, heifers 
were milked twice daily in a double 2, side opening parlor.  Lactating heifers spent the first week 
of lactation in a transition pasture where they received a total mixed ration (TMR) and had 
access to bermuda grass pasture for 3 hours.  Cows were fed twice daily at approximately 0900 
hr and 1500 hr.  Refused TMR was removed from feedbunks each day prior to the morning 
feeding.  The TMR consisted of 10 lbs of alfalfa hay, 5 lbs of whole cottonseed, 10 lbs of coarse 
ground corn, .25 lbs of sodium bicarbonate, .10 lbs of magnesium oxide, .25 lbs of soybean 
meal, and .25 lbs of a mineral premix.  Following a negative test for antibiotic residue using a 
Delvotest P MINI kit (DSM Food Specialties, Menomomee Falls, WI), heifers were moved into 
the lactating herd where they were housed in a freestall barn bedded with kiln dried sawdust.  
Bedding was cleaned twice daily and replaced weekly.  Heifers received approximately 3-8 hrs 
of pasture time outside of the freestalls each day.  Pasture consisted of Bermuda grass in the 
summer months (May thru October) and annual ryegrass in the winter months (November-
April).  
3.2 Treatment and Heifer Mammary Secretion Sampling 
Mammary secretions from individual, functional quarters were  aseptically collected in 
duplicate at 14 days prior to expected date of calving (C-14), at calving (C+0) and at 7 (C+7), 14 
(C+14) and 21 days (C+21) postpartum for microbiologic evaluation.  An aliquot of the milk 
samples taken at C+7 and C+14 were saved and frozen for analysis of milk ketones.  Teat canals 
of quarters which yielded insufficient secretion for microbiological testing at C-14 were swabbed 
as described by Trinidad, et al. 1990 (82). Additionally, composite samples were collected at 
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milkings 3, 6 and 10 postpartum for antibiotic residue testing.  All samples other than teat canal 
swabs were stored frozen at -20º C for 24 hours or more prior to microbiologic evaluation.  Teat 
canal swabs were plated immediately on blood agar.  Quarter sampling procedure at all times 
was as follows: Teat ends were scrubbed for 15-30 seconds with cotton balls soaked in 70% 
isopropyl alcohol.  The keratin plug was removed from the streak canal via manual manipulation.  
Mammary secretions were collected in 17 x 100 mm sterile polystyrene tubes with caps, until 
three quarters full.  Composite samples were taken without aseptic technique.  Debris was 
removed from each teat and 5 squirts of milk was hand stripped into a 15 ml plastic sample tube.  
Following aseptic sampling, heifers with even numbered ear tags had commercially available 
intramammary antibiotic (200mg cephapirin sodium, Fort Dodge Animal Health, Fort Dodge, 
IA) infused into each functional quarter.  Heifers with odd numbered ear tags received no 
intramammary infusion after sampling.  Teats of all heifers were immediately dipped using an 
iodine based barrier type teat dip following sampling or infusion.   
3.3 Microbiological Evaluation of Secretion 
Samples of mammary secretions from each quarter (.01 ml) were plated on corresponding 
quarters of 5% bovine blood trypticase soy agar plates containing .01% esculin.  Plates were 
incubated at 37°C for 48 hours.  Colony growth was presumptively identified as either 
Staphylococcus spp., Streptococcus spp. or coliform according to colony morphology, hemolytic 
characteristics, Gram stain and catalase test.  Bacteria presumptively identified as staphylococci 
were transferred from the original sample plate to an isolation blood agar plate.  Following 24 
hours of incubation, the isolation plate colonies were used to perform coagulase tests and were 
identified using API Staph kits (bioMérieux Vitek Inc., USA, 595 Anglum Rd, Hazelwood, 
MO).  Bacteria confirmed as streptococci using the catalase test were further classified as Group 
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B, C or other using Streptex streptococcal grouping kit (remel USA, Lenexa, KS).  Bacteria 
exhibiting a gram negative reaction to Gram staining were further identified to the species level 
using a API 20E kit (bioMérieux Vitek, Inc., USA, Hazelwood, MO).  All isolates identified to 
the species level were placed in 4 ml trypticase soy broth containing 10% glycerin and stored at 
20°C for future reference.   
A quarter was considered infected if the organism identified was found in duplicate 
samples taken on day C-14.  Quarters identified as being infected on C-14 were defined as being 
cured if all postpartum isolates were negative with respect to the prepartum isolate.  Cures in 
quarters of control heifers were considered to be spontaneous, while cures in treatment heifers 
were considered to result from antibiotic treatment at C-14.   
3.4 Somatic Cell Count 
Samples were taken at days C-14 and C+14 to compare differences between treatment and 
control groups in somatic cell count (SCC).  Additionally, SCC values determined at monthly 
Dairy Herd Improvement Association (DHIA) tests were used for each animals first 10 months 
of lactation.   Quarter samples were taken using aseptic technique and frozen for 24 hours at -
20ºC.  To run SCC, samples were thawed, and warmed to 33-37ºC in a water bath.  No 
preservative was added to the C-14 and C+14 samples, while preservative (Bromopol, D&F 
Control Systems, Inc., Dublin, CA) was used for samples taken for DHIA SCC.  Somatic cell 
count was determined using a Fossomatic electronic cell counter (ALSN Foss, Hillerød, 
Denmark).  Mammary secretions that were too viscous to pipette were diluted 1:10 with sterile 
saline as described by Trinidad, et al. (81).  All SCC were converted to somatic cell count score 
(SCS, logarithmic) using the statistics program SAS 6.12 for windows. 
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3.5 Milk Ketone Testing   
Composite milk samples from C+7 and C+14 were used to measure levels of ketone 
bodies in milk from both control and treatment heifers.  The Ketotestmc ketone test strips used 
were imported by Elanco Animal Health and provided courtesy of Dr. Ken Leslie, University of 
Guelph.  If β-hydroxybutyric acid was present in the milk samples, it passed through the reagent 
pad of the test strip and was converted by the enzyme β-hydroxybutyric dehydrogenase to 
acetoacetic acid.  Color change of the reagent pad was due to conversion of NAD to NADH, 
which reduced nitotetrazolium blue to formazan.  Formazan caused the purple color of a positive 
reagent pad for the milk ketone body β-hydroxybutyric acid.  The higher the concentration of β-
hydroxybutyric acid, the deeper the purple color observed on the reagent pad. Composite milk 
samples were frozen at -20ºC for at least 24 hours prior to testing.  Milk samples were allowed to 
thaw to room temperature prior to time of testing.  Samples were shaken gently, and the milk 
ketone reagent strips were dipped into the milk sample for 3 seconds.  The strips were removed 
from the milk and shaken twice to remove excess milk.  The strips were then placed on a 
countertop and observed for color change 1 minute after removal from milk.  Color development 
was compared to a standardized color chart and recorded as 0, 50, 100, 200, 500, or 1000µmol/L. 
3.6 Statistical Analysis 
Differences in mean values were evaluated between control and treatment groups for milk 
yield at 200 days in milk (DIM), 305 day actual milk yield, 305 day mature equivalent (ME) 
milk yield, and the first 3 months of DHIA recorded milk yield and SCC.  Additionally, 
differences in milk ketones and SCC were evaluated between heifers with at least one S. aureus 
infected quarter and those without a S. aureus infected quarter.  Differences in somatic cell count 
(SCC) were evaluated between control and treatment heifers at days C-14 and C+14.  Analysis of 
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mean values between groups for ketone levels at weeks 1 and 2, and ketone levels between 
heifers with at least one S. aureus infected quarter and heifers without a S. aureus infected 
quarter were completed.  Seasonal effect on milk ketone levels underwent preliminary analysis 
but results were discarded because of insufficient numbers resulting from poor distribution of 
animals throughout each season of the experiment.  Also, differences between control and 
treatment groups were evaluated for services per conception, days open, days to first breeding, 
and first service conception rate.  Finally, differences in quarter cure rates between groups were 
analyzed. 
Statistical evaluation was done using SAS version 6.12.  The general linear model 
procedure (PROC GLM) was used, and care was taken to account for the unbalanced sample 
population.  Statistical significance was declared at P≤0.05, while trends were declared at 













CHAPTER 4. RESULTS 
4.1 Cure Rates 
Cure rates were determined for the quarters of 20 (quarters= 80) treatment heifers and 25 
(quarters= 99) control animals.  Twenty one of twenty five heifers (84%) in the control group 
were infected in at least one quarter at 14 days before calving.  In the treatment group, 17 of 20 
heifers (85%) were infected in at least one quarter 14 days prior to parturition (Table 4.1).  
During the sampling period, one quarter was lost in the treatment group due to a fungal infection, 
and one quarter was lost in the treatment group as a result of gangrenous mastitis.  One quarter in 
the control group was nonfunctional at the beginning of the sampling period and was never 
enrolled in the study.   
 
Table 4.1. Percentage of infected heifers and quarters in control and treatment groups 
at 14 days prepartum (C-14) 
 # Heifers  # Quarters  
 Infected Uninfected % infected Infected Uninfected % infected 
Control 21 4 84 59a 39 60 
Treatment 17 3 85 41 39 51 
Total 38 7 84 100 78 56 
 
aOne quarter was not counted due to sample contamination 
 
As expected, treatment group quarters in treated heifers exhibited cure rates that were 
significantly improved compared to control quarters (P<.003).  As shown in Table 4.2, 
intramammary infections in control quarters decreased by 21% while infections in treated 
quarters decreased 78%.  Quarters with S. aureus infections decreased 23% in control heifers 
while treated heifers had an 80% decrease.  Furthermore, results suggested that control heifers 
were more likely to acquire new infections during the sampling period (P<.09).  Data for cure 
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Table 4.2. Number of infected quarters categorized by pathogen in control and treatment 
heifers 
 




(T or C) 
14 days prepartum 
C - 14 
21 days postpartum 






 C 13 8(2) 23 
  T 10 2 80 
 
CNS 
 C 33 24(1) 24 




 C 7 1(6) 0 
  T 2 0(1) 50 
 
Mixed 
SA C 3 1 66.7 
  T 1 0 100 
 Non-  C 1 0 100 
 SA T 4 0 100 
 
Other 
 C 2 2 0 
  T 0 0 — 
Total =  C 58 37(9) % 21 
  T 37 7(1) % 78 
* Numbers in parentheses indicate quarters that were cured due to postpartum 
treatment.  These quarters are not used in calculation of % reduction 
 
CNS= Coagulase negative Staphylococcus spp. 
SA= Mixed culture containing Staphylococcus aureus 
Non- SA= Mixed culture containing no Staphylococcus aureus colonies 
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Table 4.3.  Prevalence of mastitis pathogen isolation in heifers during late gestation and 
early lactation in the control group. 
 
 # Control Quarters 
  C - 14 C + 0 C + 7 C + 14 C + 21 
Uninfected  39 34 63 60 61 
Staph. aureus  13 15 6 5 8 
CNS  33 34 23 25 24 
Streptococci  7 10 2 5 2 
Mixed S. 
aureus 
3 1 __ 1 1 
 Non S. 
aureus 
1 3 1 __ __ 
Other  2 2 3 2 2 
Blind  1 1 2 2 2 
Contaminated  1 __ __ __ __ 
Total =  100 100 100 100 100 
 
 

























Table 4.4.  Prevalence of mastitis pathogen isolation in heifers during late gestation and 
early lactation in the cephapirin treatment group. 
 
 # Treatment Quarters 
  C – 14a C + 0 C + 7 C + 14 C + 21 
Uninfected  39 66 68 70 72 
Staph. aureus  10 5 3 3 2 
CNS  24 5 4 5 5 
Streptococci  2 2 1 — — 
Mixed S. 
aureus 
1 1 1 — — 
 Non S. 
aureus 
4 __ __ 1 __ 
Other  — 1 3 1 — 
Blind  — — — — 1 
Contaminated  — — — — — 
aSamples obtained before cephapirin infusion 
CNS= Coagulase negative Staphylococcus spp. 
 
Table 4.5.  Number of quarters treated for clinical mastitis during the experimental period. 
 Control  Treatment  
Pathogen isolated Treated Cured % Cured Treated Cured % Cured 
Staph. aureus 3 2 66 2 0 0 
CNS 1 1 100 --- --- --- 
Streptococci 7 6 86 1 1 100 
Other 1 0* --- 1 0* --- 
Total 12 9 75 4 1 25 
*indicates quarter was rendered non-functional. 
CNS= Coagulase negative Staphylococcus spp. 
 
 






































Figure 4.1: Percentage of uninfected quarters in control and treatment groups 
throughout sampling period 
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rates for major and minor pathogens isolated can be seen in Tables 4.2-4.5, with a summary 
shown in Figure 4.1.  
 Clinical mastitis during lactation was a problem during the sampling period of this study 
(Table 4.5).  Twelve quarters in the control group (12%) were treated for clinical mastitis while 
four quarters (6.25%) in the treatment group were treated.  Following treatment in the control 
group, 9 out of 12 quarters were cured (75%).  Treatment of clinical quarters in the treatment 
group resulted in 1 out of 4 quarters being cured (25%).  Quarters infected with S. aureus had 
cure rates of 66% and 0% for the control and treatment groups, respectively.   
4.2 Milk Production 
  There were some significant differences in milk production/lactation between groups.  
Milk yield data is presented in Table 4.6 and Figure 4.2, and persistency data in Table 4.7.  At 
200 days in milk, the control group averaged 5.8%, or 1.1 kg/day, more milk than their treatment 
group herdmates.  When comparing 305 day milk yield between groups, the control group 
produced 4.4%, or 242 kg, more milk than the treatment group.  When average of the first 3 
DHIA milk records was compared between groups, control animals averaged 5% more, or 1 
kg/day, more milk in this early lactation period.  One control animal calved with an 
intramammary fungal infection.  This quarter was rendered nonfunctional with infusion of 60cc 
2% Nolvasan.  This heifer was milked the entire first lactation with the three remaining quarters.  
Additionally, one treatment animal calved with a gangrenous right rear quarter. The organisms 
isolated from this quarter were Escherichia coli, Bacillus spp., and Streptococcus uberis.  The 
animal successfully completed her first lactation on the three remaining quarters.  Further into 
lactation, 2 treatment heifers had quarters that atrophied and became non-functional.  These 
quarters were previously infected with Staphylococcus hyicus and Staphyloccous aureus, and did 
not resolve following the prepartum intramammary treatment.   The heifers completed their 
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Table 4.6.  Comparison of milk yields of control and treatment heifers at different periods 
of lactation 
 
 n Control 
 
SE(±) n Treatment 
 




25 19.6 kg 3.9 20 18.6 kg 4.2 .28 
200 d daily 
lactation 
average 
23 19.1 kg 0.61 20 18.0 kg 0.64 .24 
305 d actual 
milk 
23 5555 kg 1158 181 5312 kg 1252 .40 
305 d mature 
equivalent 
milk 
23 7234 kg 1508 181 7146 kg 1684 .83 
Persistency, 
% 
23 108.5 22.6 19 110.8 25.4 .57 
 
 
1 Two heifers from treatment group were eliminated between days 200 and 305 of lactation, but 
lactated enough for 200 day data and one of these lactated long enough for persistency data. 
 
 
Table 4.7: Persistency1 of milk production in heifers calving in warm weather vs. cooler 
weather. 
 
 n Control SE(±) n Treatment SE(±) P 
Warm2 8 101.9 36.0 10 106.5 33.7 .46 
Cool3 15 114.5 29.6 9 115.9 38.6 .86 
Average 
Persistency 





- .05  - .13   
 
 
1 Persistency is a DHIA defined term which measures the 30 day change in Fat Corrected Milk 
2 Warm weather = May 1 - Oct. 15. 
































Figure 4.2: Comparison of average weekly milk weights: Control vs. treatment 
when milk yield was analyzed using split plot in time mixed model with 
covariate adjusted for calving date.  Milk yield was significantly different 
(P=.0001).  
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lactation with the remaining 3 quarters.  A summary of weekly production averages can be seen 
in Figure 4.2.  The average weekly milk weights were significantly different (P=.0001)  
4.3 Somatic Cell Counts 
Prepartum antibiotic therapy appeared to lower somatic cell counts in treated heifers 
(Figures 4.3-4.5).  This agrees with previous work done using both dry cow antibiotics and 
lactating cow antibiotics (53, 57, 83).  Somatic cell counts between experimental groups were 
measured for each quarter at C-14 and C+14, and then measured again using DHIA composite 
averages for the first 3 test months and the first 200 days in milk (DIM).  Complete data can be 
seen in Tables 4.8 and 4.9.  Although there were no significant differences between groups, SCS 
was lower in control on C-14, and higher on C+14.  There was a trend (P=.13) indicating control 
group quarters had differences at C-14.  As shown in Table 8, control quarters had lower somatic 
cell score (SCS) at the beginning of the trial compared to treatment quarters.  Yet, by day C+14 
control quarters had decreased 48%, whereas the treatment quarters decreased 62%.  This  
difference in SCS at C+14 was significant (P=.005), as shown in Table 4.9.  This data indicates 
that prepartum antibiotic therapy is effective in lowering cell counts in heifers.  Cell counts for 
the first three months of lactation, using DHIA records, were not different (Table 4.9).  However, 
there was a tendency for treatment heifers to have lower average cell counts than control heifers 
throughout the 3 months (P=.07).   When each month was compared individually between 
experimental groups, there were no differences.  At the second and third months there were no 
differences between experimental groups.  When cell counts were evaluated between 
experimental groups for the first 200 DIM, there were no differences but a trend was apparent 
(P=.11).  From these results it appears that prepartum treatment was effective in reducing 
somatic cell count in heifers at parturition.  Some of the effects of the treatment may persist 
throughout lactation, contributing to lower cell counts that extended into mid and late lactation.   
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Table 4.8. Comparison of individual quarter somatic cell score (SCS) between experimental 
groups at 14 days prepartum and 14 days postpartum. 
 
 14 days prepartum (C-14)  14 days postpartum (C+14)  
 RFQ LFQ LRQ RRQ  RFQ LFQ LRQ RRQ  
Control 7.6 7.8 7.5 7.7  4.4 3.5 3.5 4.4  
Treatment 8.2 8.3 8.1 7.8  3.1 3.1 2.7 3.4  
 
           
Table 4.9.  Somatic cell count score (SCS): Control vs. treatment 
 
 n Control SE(±) n Treatment SE(±) P 
1C - 14 94 7.63 .79 79 8.11 .91 .13 
1C +14 94 3.96 .41 79 3.07 .35 .005 
Month 1 25 4.16 .83 20 3.18 .71 .11 
Month 2 23 2.92 .61 20 2.43 .54 .47 
Month 3 23 3.33 .69 20 2.86 .64 .46 
2Mon 1-3 avg  25 4.15 .83 20 3.14 .70 .07 
2200 D avg. 25 4.12 .82 20 3.29 .74 .11 
 
 
1 Samples at C - 14 and C + 14 were by individual quarter, while all others were composite. 
2 Data was averaged arithmetically ((M1+M2+M3)/3) and entered into SAS as an average, while 
data for months 1-3 was entered as an independent number to be evaluated and compared by 

























































































































Figure 4.5: Somatic cell score for first 10 months of lactation: Control vs. Treatment 
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4.4 Reproduction 
 Data was evaluated for differences between services per conception, days open, days 
to first breeding, and first service conception rate as shown in Table 10 and 11.  Reproductive 
data for one heifer in the treatment group was dropped from analysis due to an abortion at 
approximately 4 months.  She remained in the herd and completed her lactation.  Treatment 
animals had a mean of 2.74 services per conception; the control animals had a mean of 3.71 
services per conception.  Despite the numerical difference, there was no significant 
difference in services per conception between experimental groups (P=.33).   Additionally, 
there were no differences in services per conception (P=.29) when animals with at least one 
S. aureus infected quarter were compared to animals without a S. aureus infection. However, 
heifers without S. aureus infection required 3.57 services per conception compared to 2.62 
services per conception in heifers without a S. aureus infection.  This is opposite to what 
would have been expected. 
Days to first breeding were similar (65 vs. 64.4) between groups.  Furthermore, the 
difference in days to first breeding between heifers with at least one S. aureus infected 
quarter, and those without a S. aureus infection were also similar (64.5 vs. 64.7).  Days open 
between experimental groups and days open for heifers with or without S. aureus 
infections were not different.  However, heifers without a S. aureus infection were open for 
33 days longer than heifers with a S. aureus infection.  Comparatively, days open between 
control and treatment groups were close (127.4 vs. 131.9).  Finally, first service pregnancy 
rates did not differ between experimental groups (P=.81), or between S. aureus infection  
groups (P=.92).  31.6% of treatment heifers were pregnant to the first breeding while 29.2% 
of control heifers were pregnant to first breeding.  All data analyzed for first service 
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Table 4.10: Reproductive data: Control vs. treatment. 
 
 n Control SE(±) n Treatment SE(±) P 
Services per 
conception 
24 3.71 .76 19 2.74 .63 .33 
Days open 231 127.4 28.2 19 131.9 29.7 .89 
Days to first 
breeding 




24 1.72 .344 19 1.68 .386 .81 
 
 
1One cow left the herd and never completed lactation, but was bred once. 
 
Table 4.11: Reproductive data for heifers with Staphylococcus aureus infections vs. 
without Staphylococcus aureus. 
 
 n SA+ SE(±) n SA- SE(±) P 
Services per 
conception 
13 2.62 .73 30 3.57 .65 .29 
Days open 121 113.3 32.7 30 146.0 26.7 .30 
Days to first 
breeding 




13 1.69 .47 30 1.71 .307 .92 
 
 
1One Staphylococcus aureus heifer was bred once, but left early in lactation. 
 





conception rate was similar, regardless of infection status or treatment status.   
4.5 Ketones 
 Milk ketone concentrations were measured at weeks 1 and 2 postpartum.  
Additionally, an investigation was made into the effects of S. aureus intramammary infection 
on ketone levels at both times.  When week 1 ketones were compared between experimental 
groups, there were no differences (P=.32).  When the ketone levels of heifers infected with S. 
aureus were compared to heifers without S. aureus infections, there were no significant 
differences (P=.96). There were no differences when milk ketone levels of heifers with S. 
aureus infections at week 2 were compared to those heifers without S. aureus infections 
(P=.31).   A more detailed comparison found that there was evidence (P=.09) of a difference 
in ketone levels at week 2, when comparing control heifers with and without S. aureus 













Table 4.12: Milk ketones (µmol/L) in control and treatment groups at weeks 1 and 2. 
 
 n Control SE(±) n Treatment SE(±) P 
Week 1 22 63.6 13.6 18 120 28.3 .32 
Week 2 22 201.4 42.9 18 166.7 39.3 .73 
 
 
Table 4.13: Milk ketone concentration (µmol/L) in heifers with and without 
Staphylococcus aureus intramammary infection 
 
 n SA SE(±) n Non  SA SE(±) P 
Week 1 9 93.1 31.0 31 90.6 16.3 .96 
















CHAPTER 5. DISCUSSION 
5.1 Cure Rates 
 Overall, infected quarters in the treatment group had higher cure rates than infected 
quarters in the control group, despite more infections present in control quarters at the onset 
of sampling.  This reinforces results of earlier studies indicating high efficacy of lactating 
cow intramammary antibiotics in heifers (52).  In this study, infection rate in control quarters 
dropped 21%, while infection rate in treated quarters decreased by 78%.  Overall infection 
rate of quarters with S. aureus decreased 23% in control quarters while decreasing 80% in 
treated quarters (Table 4.2).  These numbers are remarkably similar to results of a 1992 study 
by Oliver et al.(52). 
 The predominate bacterial species isolated were Staphylococcus spp..  Previous 
research has shown that CNS are the most common in heifers regardless of location (52, 65, 
82, 83).  Staphylococcus aureus comprised 23% of all infections at day C-14.   While this is 
greater than previously reported at other locations, (46, 49, 65), this percentage is consistent 
with previous data generated at this laboratory (82).   
 The type of pathogen, time of infection and timing of the antibiotic infusion of the 
gland may affect efficacy (53).  One objective of this study was to sample all animals 14 days 
before calving.  The average time of antibiotic administration in this study was 16 days 
before calving.  It is possible that concentrations of antibiotics could decrease to non-
therapeutic levels if the drug was administered too many days prior to calving.  The time 
between decreased levels of antibiotic and calving may provide a window of opportunity for 
new IMI to occur, especially given the immunosuppression inherent in periparturient dairy 
cows.  From C-14 to C+0, the control group acquired 2 new S. aureus, 1 new CNS, and 3 
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new Streptococcus spp. intramammary infections, while the treatment group acquired only 1 
new coliform infection during the same time period.  This indicates that infused antibiotics 
not only have an effect on cure rates for pre-existing infections, they also have a protective 
effect against new infections acquired in the periparturient period.    
5.2 Milk Production 
  Past research has shown a significant increase in milk production of heifers treated 
with intramammary antibiotics prepartum (52, 53, 57).  These researchers found Jersey 
heifers treated with antibiotics (n=114) at 7 and 14 days prepartum produced 531 kg more 
milk per lactation than control heifers (n=83).  The increased milk production is commonly 
thought to occur from eradicating infections within the mammary gland and preventing 
damage to the secretory cells.  However, the control group produced significantly more milk 
treatment groups in our study (Figure 4.2).  This is in contradiction to previous studies 
examining milk production in heifers treated prepartum (53).  In our trial, lower infection 
rates in the control group before calving may have had an effect on milk production.  The 
control group had SCS that was 6% lower than the treatment group at C-14 (Table 4.9).  This 
lower SCS would indicate a lower initial infection rate in the control group, which may have 
contributed to higher milk production by control heifers throughout the lactation (Figure 2).   
An additional contributing factor may have been genetics.  Efforts were made to 
examine genetic differences in Predicted Transmitting Ability (PTA) milk between the 
groups, but the number of animals unregistered or with unknown sires made this impossible.  
In a small research population, it would require very few genetically superior heifers to skew 
the data towards one group or another.  Future studies may want to pay special attention to 
the number and genetics of trial animals.  Additionally, the seasonal effect of calving, 
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warmer weather vs. cooler weather may have altered the data.  It is well documented that 
lactating dairy cows are sensitive to heat stress.  As ambient temperature and humidity 
increase, dry matter intake, milk production, and estrous activity decrease (88).  In our study, 
more heifers in the treatment group calved during hot weather than in the control group.  Of 
the 20 animals in the treatment group, 6 (30%) calved in mild weather (October 15 thru May 
1).  Of the 25 animals in the control group, 10 (40%) calved in mild weather.  These 
differences could have been magnified by the small population of the experimental groups.   
In mild weather, dairy heifers would be expected to have higher dry matter intake, less fly 
stress, less heat stress and less overall metabolic stress.  It would be expected that production 
would be slightly higher in heifers calving in mild weather, than in those calving in July, 
August, and September, as did the remainder of the treatment heifers.  Table 5.1 shows the 
breakdown of heifers calving by season, as defined by the western calendar.  It could be 
extrapolated that heifers calving during the cooler months and those that continued lactation 
during cooler months would be expected to have higher persistency and milk yield (19, 36).  
Persistency in milk production did not differ between treatment groups but did differ between 
warm or cold weather calving heifers in this trial (Table 4.9).  Previous research has shown 
that environmental factors have an effect on milk yield and persistency in lactating sheep (19, 
71).  The low number of experimental animals, short duration of the trial, loss of infected 
quarters in the experimental groups, possibility of previous mammary gland damage prior to 
antibiotic infusion and unintentional bias in pedigree could have contributed to the lack of 
differences in milk production between groups.  Future research should be extended in time 
to further investigate seasonal effects, and increase the number of control and treatment 
animals.   
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Table 5.1. Distribution of heifers calving by season 
      Winter 
(Dec 21-Mar. 20) 
Spring 
(Mar. 21-Jun. 20) 
Summer 
(Jun. 21- Sept. 20) 
Fall 
(Sept. 21-Dec. 20) 
11 5 26 3 
 
 
5.3 Somatic Cell Count 
Somatic cell count (SCC) was expected to decrease in this trial as was shown in 
previous research with primiparous heifers.  Somatic cell count (SCC) was converted to 
logarithmic somatic cell score (SCS).  Somatic cell score was measured between treatment 
groups at 14 days before calving (C-14), 14 days after calving (C+14), the first 3 months of 
lactation, and monthly through the first 200 days after calving using the first 10 DHIA 
records of each animal.  SCS measured at 14 days before and 14 days after calving were 
taken for individual quarters while all other samples were a composite of all four quarters.  
Somatic cell count score (SCS) was lower in treated heifers than in control heifers throughout 
all stages of lactation, except for C-14. 
 SCC in heifers at C-14 did not differ between groups (Table 4.7).  However, there 
was a trend towards the control group having lower SCS.  It was assumed that SCS would be 
similar at the beginning of the study.  The fact that the control heifers had lower cell counts 
before treatment, but decreased only by 24%, compared to 79% in treated heifers, illustrates 
the potential of prepartum intramammary antibiotics.  It is documented in the literature that 
cows with lower somatic cell counts yield more milk (67).  While no significant differences 
in milk production were apparent, the differences in cell count indicate a potential for 
increased milk production from heifers treated with intramammary antibiotics.  This would 
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concur with the work of Oliver, et al. (53) which found that heifers treated with lactating cow 
antibiotics produced 531 kg more milk per 305 day lactation than their control counterparts.   
 When DHIA SCS records were analyzed for the first 3 months of lactation, the 
treated heifers were consistently lower than control heifers during all 3 months; however 
differences were not significant at any month of lactation.   A trend was apparent at Month 1 
of lactation towards lower SCS in treated heifers, but disappeared at Months 2 and 3.  SCS 
was 23.6, 16.8 and 14.2% lower in treated heifers at Months 1, 2 and 3 respectively.  At first 
glance it appears the differences in SCS during the first 3 months of lactation are not strong.  
However, when the first three months of lactation for each heifer was averaged and then 
analyzed, the difference between experimental groups was almost significant, and there was 
evidence of a trend at P=.07.   The 200 day monthly SCS was analyzed the same way, and it 
displayed a trend for lower SCS (P=.11).  Given the variation in DHIA testing, averaging 
provides a closer estimate of actual SCS.  Averaging will dilute the effect of an abnormally 
high score caused by incorrect labeling, misreading a label, or a nervous heifer failing to let 
her milk down on test day.  Conversely, if one was looking at the behavior of SCS curves 
throughout the 200 day period, averaging could destroy any meaningful data.  We included 
data for both types of analysis of SCS where applicable. 
5.4 Reproduction 
Differences in reproductive performance between experimental groups were 
measured using services per conception, days open, days to first breeding and first service 
conception rate as indices of reproductive efficiency.  Additionally, differences in these 
indices were assessed between heifers with Staphylococcus aureus infections and heifers 
without S. aureus infections.     
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 Although control heifers required almost one additional breeding before pregnancy 
(3.71 breedings/ conception) compared to treatment heifers (2.74 breedings/conception), 
differences were not significant (Table 4.11).  University of Tennessee researchers examined 
reproductive performance of cows (n=205) that had clinical mastitis.  Cows with clinical 
mastitis required 2.9 breedings/ conception compared to 1.7 breedings in cows with no 
clinical mastitis (2).  This difference was significant (P=.01).  In our study, days open, days 
to first breeding, and first service conception rate did not differ between experimental groups.   
 The differences between heifers with S. aureus intramammary infections and those 
without were perplexing.  One would expect that heifers with S. aureus, a major mastitis 
pathogen, would have decreased reproductive performance.  Yet, heifers without S. aureus 
infections required 3.57 breedings per conception while heifers with S. aureus infections 
required 2.62 breedings per conception.  Furthermore, heifers without S. aureus infections 
had 146 days open while heifers with S. aureus had 113 days open.  While this data was not 
significant, it was interesting nonetheless.  However, the likelihood of skewness caused by a 
unbalanced experimental population is high.   
There is a scientific basis to indicate differences in reproductive performance between 
heifers with mastitis and heifers without mastitis (2, 24).  Hockett, et al. (24) theorized that 
clinical mastitis may cause a change in prostaglandin F2α (PGF2α) release.  Furthermore, they 
determined that if concentrations of PGF2α were elevated, a decrease in embryonic 
development and quality in addition to luteal regression may occur.   While that study was 
done on cows induced with experimental intramammary infections, it begins to explain 
possible effects of mastitis on reproduction at the cellular level.  Further research is 
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warranted to determine the full relationship between clinical and sub-clinical mastitis caused 
by gram- positive pathogens and decreased reproductive performance.   
5.5 Ketones 
 The metabolic effect of clinical or sub-clinical mastitis in cattle has received little 
attention.  First calf heifers generally do not show signs of clinical ketosis and research to 
determine the effects of ketosis on the immune system in vitro have been conflicting (16, 29).    
Ketone levels were measured between treated and control heifers at 7 and 14 days 
postpartum.  There were no differences or trends apparent between experimental groups at 
either time.  Additionally, ketone concentrations between heifers with S. aureus 
intramammary infections and heifers without S. aureus were evaluated.  There were no 
statistical differences or trends, however control heifers consistently had higher ketone 
concentrations throughout both weeks when averaged.  As seen in Tables 4.12 and 4.13, 
there were no differences or trends between the treatment groups. 
 Lactating cows normally have low concentrations of circulating ketone bodies due to 
the metabolic demand of lactation.  When glucose demand exceeds the gluconeogenic 
capacity of the liver, clinical ketosis develops as ketone concentrations increase in the 
system.  Risk factors for ketosis include herd, parity, genetics, season and body condition 
(31).  Higher milk ketone levels were observed at week 2.  Previous studies showed that peak 
incidence of ketones occurred at weeks 2 and 3 postpartum (20, 31).  However, at week 1 10-
30% of cows had subclinical ketosis.  This data indicates that measurement of ketone 
concentrations may have been more useful if done at week 3 post-calving.  Milk samples 
were obtained at the AM (0200 h) or PM (1300 h) milking for determination of ketones .  
Research indicates additional variables that may skew milk ketone levels as measured here 
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(20).  These include high milk SCC, feeding of poor silage and diurnal variation.  Perhaps 
future studies should extract milk samples at a uniform time of day.  Furthermore, a more 
detailed analysis of milk ketones in cows with high SCC may have been productive.  We 
examined the relation between cows with S. aureus infections and concentration of milk 
ketones.  Given that cows with S. aureus display high SCS, the somewhat higher levels of 
ketone bodies present in these animals present a problem.  Were the slightly higher ketones 
in S. aureus heifers really elevated or were they due to increased SCC?  The low 
experimental numbers in our study prevent us from making any conclusions. Control heifers 
had significantly higher SCS than treatment heifers at week 2 and during the first month of 
lactation, when the ketone samples were taken.  Future studies should examine this problem 
and provide means for measuring physiological ketone levels other than or in conjunction 
with milk ketone levels.   
 Given the relation between negative energy balance and poor reproductive 
performance, perhaps an analysis of heifers with high ketone concentrations and their 
subsequent reproductive performance would be beneficial.  Results from this study could 
warrant further studies examining the relationship between sub-clinical mastitis and overall 








CHAPTER 6. SUMMARY 
There were three objective of this study:  One was to determine the effect of a 
lactating cow cephapirin product administered two weeks prepartum on existing 
intramammary infections in primigravid dairy heifers.  Second, to determine the effect of a 
lactating cow cephapirin product administered two weeks prepartum on milk production and 
somatic cel count in primiparous dairy heifers.  Third was to evaluate the effect of a lactating 
cow cephapirin product administered two weeks prepartum on reproductive performance and 
metabolic status in primiparous heifers. 
 Forty six primigravid Jersey heifers from the Hill Farm mastitis research laboratory 
dairy were randomly assigned to treated or control groups.  Animals with even numbered ear 
tags (n=21) were assigned to the treated group while animals with odd numbered ear tags 
were assigned to the control group (n=25).  Treated animals received an intramammary 
infusion of 200mg cephapirin sodium in each quarter (Fort Dodge Animal Health, Fort 
Dodge, IA) 14 days prior to expected date of parturition.  Control animals received no 
infusion.  The study was initiated in January 2002 and completed in April 2003.  Criteria 
examined included cure rates, milk production, somatic cell count, milk ketone concentration 
and reproductive performance.  Additionally, seasonal effects on milk persistency and 
ketones were examined, as well as the effect of S. aureus intramammary infections on ketone 
levels and reproductive performance.   
The intramammary infusion of lactating cow antibiotics 14 days prepartum decreased 
the number of infected quarters by 78% in treated group.  Spontaneous cure rate in control 
heifers was 21%.  Cure rate of quarters with S. aureus in treated heifers was 80%, while the 
control heifers had a spontaneous recovery rate of 23%.   
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There were statistical differences in milk production between groups during the study.  
Control heifers consistently produced more milk throughout the entire lactation than treated 
heifers (P=.0001).  Production at other times was also higher in the control heifers, but not 
significantly different.  Reasons for unexpected production by the control group may include 
genetic differences and season of calving.  When persistency of milk production was 
measured, control heifers were more persistent when calving during cool weather as 
compared to warm weather (P=.05).  Treated heifers had a trend towards increased 
persistency when calving during cool weather (P=.13).   
Intramammary treatment lowered somatic cell count score in treated heifers as 
compared to control heifers at day C+14 (P=.005).  Treated heifers had a tendency for lower 
SCC than control heifers during the first 3 months of lactation (P=.07) and the first 200 days 
of lactation (P=.11).   
There were no significant differences in reproductive performance between groups.  
Control heifers required more services per conception (3.71) than treated heifers (2.74) but 
the difference was not significant (.33).  Heifers with S. aureus infections required fewer 
breedings per conception (2.62) than heifers without S. aureus infection (3.57) however the 
difference was not significant (P=.29).  Also, heifers with S. aureus infections had fewer days 
open (n=113) than heifers without S. aureus (n=146) but the difference was not significant 
(P=.30). 
Milk ketone levels were measured at weeks 1 and 2 postpartum.  There were no 
differences in the concentration of milk ketones between groups at either time.  Additionally, 
there were no differences in milk ketones between heifers with S. aureus infections and those 
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without.  However, heifers with S. aureus infections consistently had higher milk ketone 
levels than those without.   
In conclusion, some useful information was confirmed by this study.  Prepartum 
intramammary antibiotics will significantly improve cure rates in primiparous heifers.  It also 
trended to lower somatic cell count scores.  There was a tendency for treatment to have an 
effect on reproduction and ketone levels, but this was not strong enough to draw conclusions.  
Additional research is still needed to determine effects of prepartum, intramammary 
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